NCT00564902View on ClinicalTrials.gov

The Zeaxanthin and Visual Function Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions
Age Related Macular DegenerationCognition Disorders
Interventions
DRUG

3R 3'R Zeaxanthin

8 mg per day during 12 months

DIETARY_SUPPLEMENT

Lutein

9 mg of Lutein during 12 months

DIETARY_SUPPLEMENT

Lutein and Zeaxanthin

8 mg of lutein and 8 mg of Zeaxanthin administered during 12 months

Trial Locations (1)

60064

North Chicago VA Medical Center, North Chicago

All Listed Sponsors
collaborator

Kowa Company, Ltd.

INDUSTRY

collaborator

IMAGE TECHNOLOGIES INC.

INDUSTRY

lead

Chrysantis, Inc.

INDUSTRY

NCT00564902 - The Zeaxanthin and Visual Function Study | Biotech Hunter | Biotech Hunter